Ligand to Divest Combinatorial Compound Library and Screening Technology for $1.8 Million
Ligand Enters into Agreement with Proximagen for CXCR4 Target
Ligand to Present at the Stifel Nicolaus Healthcare Conference on September 17
Ligand Pharmaceuticals Announces Second Quarter Results
Ligand to Present at the BMO Capital Markets Healthcare Conference on August 5
Ligand to Report Second Quarter Results on August 5th
Ligand Launches New Corporate Web Site
Ligand to Webcast Analyst Day on June 24
Ligand Board Authorizes Reverse Stock Split and $10 Million Share Repurchase
Ligand to Present at the Jefferies Global Life Sciences Conference on June 9
Ligand Acquired Milestone and Royalty Interest in AstraZeneca IL-9 Program for Asthma
Ligand to Present at the MDB Capital Group Bright Lights Conference on May 11
Ligand Pharmaceuticals Announces First Quarter Results
Ligand to Report First Quarter Results on May 5th
